4.7000
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-354,550.0000
-341,691.0000
-41,227.0000
-245,843.0000
-62,622.0000
Investing Cash Flow
482,005.0000
59,681.0000
-628,848.0000
-467,542.0000
-6,700.0000
Financing Cash Flow
-8,276.0000
23,139.0000
273,487.0000
894,870.0000
644,617.0000
End Cash Position
708,974.0000
259,548.0000
515,047.0000
910,755.0000
729,270.0000
Capital Expenditure
-11,939.0000
-13,304.0000
-12,377.0000
-13,260.0000
-6,700.0000
Issuance of Capital Stock
--
30,959.0000
279,849.0000
900,794.0000
650,437.0000
Free Cash Flow
-366,489.0000
-354,995.0000
-53,604.0000
-259,103.0000
-69,322.0000
12/31/2020 - 9/3/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNBIF SanBio Company Limited
4.6500
0.00%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
HNSBF Hansa Biopharma AB (publ)
3.0000
0.00%
MLLCF Molecular Partners AG
4.2200
0.00%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
PBIGF Paradigm Biopharmaceuticals Limited
0.3280
0.00%
OXBDF Oxford Biomedica plc
5.56
0.00%
IPHYF Innate Pharma S.A.
2.9000
0.00%
VBIZF Viva Biotech Holdings
0.0950
0.00%
TRGNF Transgene SA
1.5900
0.00%